Literature DB >> 16027557

Achieving adequate outcomes in geriatric depression: standardized criteria for remission.

David J Kupfer1.   

Abstract

In the management of late-life depression, a major set of issues concerns the terms or language used to describe the course of illness and response to treatment. There appear to be considerable advantages in the application of standardized remission criteria. If one is primarily concerned with symptomatic remission and the resolution of a single or initial episode of depression, then a moderately strict criterion is sufficient, for example, Hamilton Rating Scale for Depression (HRSD) < or = 10. However, as the goal of treatment is to achieve complete recovery, which may reduce the risk for either relapse or recurrence, then there may be a strong advantage in applying a more stringent remission criterion such as HRSD < or = 6 or 7. The characteristics of the response pattern (ie, trajectory of clinical course) also can provide important prognostic information. Such pattern characteristics can be modeled with newer statistical methods, which in turn can better inform the course of future treatment. Finally, there is growing recognition that standardized remission criteria can be valuable for establishing treatment guidelines for late-life depression, as well as for educating clinicians and consumers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027557     DOI: 10.1097/01.jcp.0000168488.99268.e5

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  5 in total

1.  Cognitive impairments and depressive symptoms did not impede upper limb recovery in a clinical repetitive task practice program after stroke: a pilot study.

Authors:  Elizabeth R Skidmore; James T Becker; Ellen M Whyte; Lynne M Huber; Laura F Waterstram; Amalie Andrew Ward; Emily S Grattan; Margo B Holm
Journal:  Am J Phys Med Rehabil       Date:  2012-04       Impact factor: 2.159

2.  Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.

Authors:  Daniel M Blumberger; Benoit H Mulsant; Chetachi Emeremni; Patricia Houck; Carmen Andreescu; Sati Mazumdar; Ellen Whyte; Anthony J Rothschild; Alastair J Flint; Barnett S Meyers
Journal:  J Psychiatr Res       Date:  2011-02-05       Impact factor: 4.791

3.  White Matter Hyperintensity Accumulation During Treatment of Late-Life Depression.

Authors:  Alexander Khalaf; Kathryn Edelman; Dana Tudorascu; Carmen Andreescu; Charles F Reynolds; Howard Aizenstein
Journal:  Neuropsychopharmacology       Date:  2015-06-10       Impact factor: 7.853

4.  Contemporary concepts in the pharmacotherapy of depression in older people.

Authors:  Carlos Rojas-Fernandez; Mina Mikhail
Journal:  Can Pharm J (Ott)       Date:  2012-05

5.  Remission from Depression in the DSM: Moving from Rhetoric to Restoration.

Authors:  Paige Gesicki; Holly Nelson-Becker
Journal:  Clin Soc Work J       Date:  2017-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.